• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Society for Medical Oncology (ESMO) - Articles and news items


Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Industry news / 6 July 2015 / Victoria White

Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress…


Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer

Industry news / 3 July 2015 / Victoria White

The Phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)…


ESMO highlights the opportunities and challenges to come from the EU Clinical Trials Regulation

Industry news / 28 May 2015 / Victoria White

ESMO, in collaboration with EORTC, have expressed their views on the EU Clinical Trials Regulation in an official position paper…


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +